Pura Vida Investments, LLC Bellus Health Inc. Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.46 - $10.02 $1.73 Million - $2.69 Million	-268,097 Reduced 68.73%	122,000 $1.13 Million
Q1 2022 May 16, 2022	BUY	$5.56 - $7.99 $12,788 - $18,377	2,300 Added 0.59%	390,097 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $278,737 - $439,833	52,992 Added 15.83%	387,797 $3.12 Million
Q3 2021 Nov 15, 2021	BUY	$2.7 - $6.64 $903,973 - $2.22 Million	334,805 New	334,805 $2.06 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.